- Immunocompromised host
- Fragile population
- SARS-CoV-2
- Post-COVID-19
Population: Immunocompromised host
An individual with an impaired immune system due to conditions such as HIV, cancer, organ transplantation, or immunosuppressive therapy
- Adults
- People at high risk of STIs
- People living with HIV
- Immunocompromised host
- Fragile population
- PrEP users
- Hospital wide
- Outpatient clinic
- Infectious diseases unit
- Monkeypox virus
- Monkeypox virus infection
- Adults
- Elderly
- Immunocompromised host
- Fragile population
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- AZD3152
- Monoclonal antibodies
- Adults
- People at high risk of STIs
- People living with HIV
- Immunocompromised host
- Fragile population
- PrEP users
- Non-hospital health centre
- Telemedicine
- Monkeypox virus
- Monkeypox virus infection
- Vaccination
- Pharmacological intervention
- Adults
- Elderly
- People at high risk of STIs
- People living with HIV
- Immunocompromised host
- Fragile population
- PrEP users
- Outpatient clinic
- Non-hospital health centre
- STD/STI clinic
- Monkeypox virus
- Monkeypox virus infection
- Adults
- Elderly
- Immunocompromised host
- Fragile population
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Acute SARS-CoV-2
- Adults
- People living with HIV
- Immunocompromised host
- Fragile population
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Adults
- Elderly
- Immunocompromised host
- Fragile population
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Acute SARS-CoV-2
- Non pharmacological intervention
- Convalescent plasma
- Adults
- Paediatric
- Elderly
- Immunocompromised host
- Fragile population
- Outpatient clinic
- Non-hospital health centre
- Community
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Monoclonal antibodies
- Sotrovimab